SCHEMBL29801034

SCHEMBL29801034

COc1ccc(CSc2nccnc2Cl)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.50
ALDH1A1 P00352 2/20 0.50
LMNA P02545 1/20 0.50
APP P05067 1/20 0.46
TP53 P04637 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
TSHR P16473 1/20 0.43
HPGD P15428 1/20 0.43
MAOA P21397 2/20 0.43
MAOB P27338 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
MAPT P10636 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26964231 1.00 SMN1; SMN2 (0.50) SMN1; SMN2ALDH1A1LMNAAPPTP53
SCHEMBL29069665 0.80 APP (0.42) SMN1; SMN2ALDH1A1LMNAAPPTP53
SCHEMBL26964284 0.79 APP (0.44) SMN1; SMN2ALDH1A1LMNAAPPTP53
SCHEMBL26964234 0.77 TP53 (0.53) SMN1; SMN2ALDH1A1LMNAAPPTP53
SCHEMBL2099509 0.76 TP53 (0.52) SMN1; SMN2ALDH1A1APPTP53TDP1
SCHEMBL16334065 0.76 TP53 (0.52) SMN1; SMN2ALDH1A1LMNAAPPTP53
SCHEMBL16334362 0.75 TP53 (0.51) SMN1; SMN2ALDH1A1LMNAAPPTP53
SCHEMBL29661774 0.73 MAOB (0.52) SMN1; SMN2ALDH1A1LMNAAPPTP53
SCHEMBL190495 0.73 MAOB (0.52) SMN1; SMN2ALDH1A1LMNAAPPTP53
SCHEMBL27595525 0.73 MAPT (0.50) SMN1; SMN2LMNAAPPTP53TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4291555-A1 SULFONAMIDES AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES Celgene Corporation (US) 2023-12-20 EP disclosed
CN-116806218-A Sulfonamide and its use for the treatment of parasitic helminth infections and diseases 新基公司 2023-09-26 CN disclosed
WO-2022173727-A1 SULFONAMIDES AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES CELGENE CORPORATION (US) 2022-08-18 WO disclosed